TipRanks
Go Ultimate55% OFF

Aura (AURA) AI Stock Analysis

IL:AURA

Aura

(TASE:AURA)

Select Model
Rating:46Neutral
Price Target:ILA 1,642.00â–¼(-5.90% Downside)
Action:reiterated
Date:10/29/26

The overall score is heavily pressured by a precarious financial structure. The most significant risk is the deeply negative operating cash flow (-ILS 1.0B) combined with a highly leveraged balance sheet, which creates material liquidity risk. While the company demonstrates strong revenue growth and reasonable valuation, the bearish technical trend and severe cash consumption outweigh these positives, resulting in a low score.

Positive Factors
Revenue GrowthRevenue growth provides evidence of continued business expansion and stronger top-line activity. If maintained, this momentum can support operating scale, improve the company’s ability to absorb fixed costs, and create a broader base for sustaining profitability over the next several quarters.
Negative Factors
Rising LeverageThe sharp increase in debt-to-equity and absolute debt reduces financial flexibility and makes results more sensitive to funding conditions. Elevated leverage can constrain future investment, increase financing-related pressure, and leave the company less able to absorb operational or market setbacks.

Aura (AURA) vs. iShares MSCI Israel ETF (EIS)

-40%-30%-20%-10%0%10%20%30%40%IL:AURA-23.37%EIS+13.14%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
ILS 4.96B
Dividend Yield
1.11%
Average Volume (3M)
509.88K
Price to Earnings (P/E)
18.6
Beta (1Y)
1.78
Revenue Growth
47.76%
EPS Growth
-2.38%
Country
Israel
Employees
223
Sector
General
Sector Strength
55
Industry
Real Estate - Development

Aura Business Overview & Revenue Model

Company Description

Established in 1992 and based in Tel Aviv, Israel, Aura Investments Ltd. is an Israeli real estate firm dedicated to the conceptualization and execution of property developments. Its operations primarily involve the construction of new residential bu...

How the Company Makes Money

As a clinical-stage biotechnology company, Aura Biosciences has not publicly established recurring product revenue from commercialized therapies. Revenue, if any, is typically generated from non-commercial sources such as collaboration/licensing arra...

Aura Financial Statement Overview

Summary

Financial performance is a tale of two extremes. The income statement is strong with 10%+ revenue growth and healthy 26% gross margins, but the balance sheet is highly leveraged (debt-to-equity of 2.46x) and cash flow is deeply negative (-ILS 1.0B TTM). The severe cash burn and rising leverage overshadow operational growth, resulting in a low overall financial score.

Income Statement

72Positive

Balance Sheet

45Neutral

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.24B1.90B1.52B1.04B849.01M893.89M
Gross Profit583.02M486.15M347.51M190.98M139.44M137.10M
EBITDA652.82M589.25M477.33M208.47M205.55M182.64M
Net Income269.89M280.75M360.14M117.69M140.54M113.53M
Balance Sheet
Total Assets8.45B7.87B4.88B3.14B2.60B1.86B
Cash, Cash Equivalents and Short-Term Investments530.83M663.97M137.03M129.36M73.21M67.45M
Total Debt4.12B3.32B2.26B1.36B845.63M828.08M
Total Liabilities6.51B6.00B3.59B2.24B1.93B1.34B
Stockholders Equity1.67B1.61B1.27B882.03M652.64M520.38M
Cash Flow
Free Cash Flow-1.01B-925.57M-127.40M-565.56M163.03M207.27M
Operating Cash Flow-1.00B-921.50M-122.29M-564.73M167.92M207.99M
Investing Cash Flow155.13M170.56M-412.89M-5.13M-141.69M-56.88M
Financing Cash Flow1.05B972.09M540.60M607.07M-26.42M-194.34M

Aura Technical Analysis

Technical Analysis SentimentNegative
Last Price1745.00

Price Trends

50DMA1731.65Positive
100DMA1717.84Positive
200DMA1928.43Negative

Market Momentum

MACD21.95Positive
RSI48.52Neutral
STOCH20.53Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AURA, the sentiment is Negative. The current price of 1745.00 is above the 20-day moving average (MA) of 1739.75, above the 50-day MA of 1731.65, and below the 200-day MA of 1928.43, indicating a neutral trend. The MACD of 21.95 indicates Positive momentum. The RSI at 48.52 is Neutral, neither overbought nor oversold. The STOCH value of 20.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:AURA.

Aura Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:AURA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:SMTIL:SMT65NeutralILS 2.75B5.35―10.56%64.49%132.97%
IL:ARGOIL:ARGO63NeutralILS 3.02B10.19――37.38%35.54%
IL:AFPRIL:AFPR62NeutralILS 7.49B6.74――3.34%44.21%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IL:AURAIL:AURA46NeutralILS 4.96B18.56―1.11%47.76%-2.38%
IL:ELCREIL:ELCRE32UnderperformILS 1.28B-6.04――5.23%29.87%

* General Sector Average

Performance Comparison

-50%-25%0%25%IL:AURAIL:SMTIL:AFPRIL:ELCREIL:BLSRIL:ARGODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IL:AURA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:AURAAura Investments Limited1745.00-545.02-23.80%
IL:SMTSummit Real Estate Holdings Ltd3967.00-2510.00-38.75%
IL:AFPRAFI Properties Ltd17900.00-4120.00-18.71%
IL:ELCREElectra Real Estate Ltd.1536.00-3045.91-66.48%
IL:BLSRBlue Square Real Estate Ltd30000.00-7639.39-20.30%
IL:ARGOArgo Properties NV12820.00700.005.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026